Data / Form D filings / RESVERLOGIX CORP.
RESVERLOGIX CORP.: Form D filings
RESVERLOGIX CORP., a biotechnology company in Calgary, Alberta, Alberta, Canada, filed 2 Form D notices with the SEC in 2011. The latest, on December 1, 2011, reports $1.8 million sold of a $1.8 million offering to 1 investor.
Find out what RESVERLOGIX CORP. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- SUITE 202, 279 MIDPARK WAY S.E., Calgary, Alberta, Alberta, Canada, T2X 1
- Phone
- (403) 254-9252
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Alberta, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1372821
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 1, 2011 | New notice | $1,841,995 | $1,841,995 | $0 | 1 | Nov 29, 2011 | sec.gov |
| Jun 21, 2011 | New notice | $10,486,899 | $10,486,899 | $0 | 7 | Jun 14, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kenneth J. Zuerblis | Director | |
| Gregory S. Wagner | Executive Officer | |
| Arthur J. Higgins | Director | |
| Kenneth O. Lebioda | Executive Officer | |
| A. Brad Cann | Executive Officer | |
| Donald J. McCaffrey | Executive Officer, Director | |
| Norman C.W. Wong | Executive Officer | |
| Peter Allan Johann | Director | |
| Kelly J. McNeill | Director | |
| F. Allan Gordon | Executive Officer | |
| Jan O. Johansson | Executive Officer | |
| Eldon R. Smith | Director |
Every Form D from the week of Nov 28, 2011 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RESVERLOGIX CORP. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.